Literature DB >> 16782931

Prognostic value of nodal ratios in node-positive breast cancer.

Wendy A Woodward1, Vincent Vinh-Hung, Naoto T Ueno, Yee Chung Cheng, Melanie Royce, Patricia Tai, Georges Vlastos, Anne Marie Wallace, Gabriel N Hortobagyi, Yago Nieto.   

Abstract

PURPOSE: The American Joint Committee on Cancer staging system for breast cancer was recently updated to reflect the impact of increasing the absolute number of positive lymph nodes on prognosis. However, numerous studies suggest that nodal ratios (absolute number of involved nodes-number of nodes resected) may have greater prognostic value than absolute numbers of involved nodes. Here we examine the data supporting the use of nodal ratios in breast cancer prognosis and consider the potential advantages and disadvantages of including nodal ratios in breast cancer staging.
METHODS: A systematic review of the literature was conducted using the following search engines: http://www.google.com; Thomson's ISI Web of Science; PubMed.
RESULTS: In multiple reports from both prospective and retrospectively collected data sets, nodal ratios have been shown to be significant predictors of outcome, including locoregional recurrence and overall survival. These studies span all stages of breast cancer and include various treatments as well as various statistical approaches.
CONCLUSION: There is considerable data supporting the use of nodal ratios in breast cancer prognosis. A thorough and methodological evaluation of the potential prognostic importance of nodal ratios in large multicenter data sets is merited and is currently being undertaken by the International Nodal Ratio Working Group.

Entities:  

Mesh:

Year:  2006        PMID: 16782931     DOI: 10.1200/JCO.2005.03.1526

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  64 in total

1.  Diagnostic and prognostic correlates of preoperative FDG PET for breast cancer.

Authors:  Vincent Vinh-Hung; Hendrik Everaert; Jan Lamote; Mia Voordeckers; Hilde van Parijs; Marian Vanhoeij; Guy Verfaillie; Christel Fontaine; Hansjoerg Vees; Osman Ratib; Georges Vlastos; Mark De Ridder
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-07-10       Impact factor: 9.236

2.  Lateral Neck Lymph Node Characteristics Prognostic of Outcome in Patients with Clinically Evident N1b Papillary Thyroid Cancer.

Authors:  Laura Y Wang; Frank L Palmer; Iain J Nixon; R Michael Tuttle; Jatin P Shah; Snehal G Patel; Ashok R Shaha; Ian Ganly
Journal:  Ann Surg Oncol       Date:  2015-02-10       Impact factor: 5.344

3.  Prognostic significance of nodal ratio in cutaneous squamous cell carcinoma of the head and neck.

Authors:  Aviram Mizrachi; Tuvia Hadar; Naomi Rabinovics; Thomas Shpitzer; Dan Guttman; Raphael Feinmesser; Gideon Bachar
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-05-13       Impact factor: 2.503

Review 4.  Minimal disease in sentinel nodes.

Authors:  Gábor Cserni
Journal:  Pathol Oncol Res       Date:  2008-05-21       Impact factor: 3.201

Review 5.  Nodal metastases in thyroid cancer: prognostic implications and management.

Authors:  Laura Y Wang; Ian Ganly
Journal:  Future Oncol       Date:  2016-03-07       Impact factor: 3.404

6.  A critical evaluation of lymph node ratio in head and neck cancer.

Authors:  M de Ridder; C C M Marres; L E Smeele; M W M van den Brekel; M Hauptmann; A J M Balm; M L F van Velthuysen
Journal:  Virchows Arch       Date:  2016-09-18       Impact factor: 4.064

7.  Lymph node ratio may be supplementary to TNM nodal classification in node-positive breast carcinoma based on the results of 2,151 patients.

Authors:  Nüvit Duraker; Bakir Bati; Zeynep Civelek Çaynak; Davut Demir
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

8.  The prognostic superiority of log odds of positive lymph nodes in stage III colon cancer.

Authors:  Jiping Wang; James M Hassett; Merril T Dayton; Mahmoud N Kulaylat
Journal:  J Gastrointest Surg       Date:  2008-08-16       Impact factor: 3.452

9.  Impact of Lymph Node Ratio and Adjuvant Therapy in Node-Positive Endometrioid Endometrial Cancer.

Authors:  Nicole D Fleming; Pamela T Soliman; Shannon N Westin; Ricardo dos Reis; Mark Munsell; Ann H Klopp; Michael Frumovitz; Alpa M Nick; Kathleen Schmeler; Pedro T Ramirez
Journal:  Int J Gynecol Cancer       Date:  2015-10       Impact factor: 3.437

10.  The impact of the lymph node ratio is greater than traditional lymph node status in stage III colorectal cancer patients.

Authors:  Yen-Jung Lu; Pei-Ching Lin; Chun-Chi Lin; Huann-Sheng Wang; Shung-Haur Yang; Jeng-Kai Jiang; Yuan-Tzu Lan; Tzu-Chen Lin; Wen-Yi Liang; Wei-Shone Chen; Jen-Kou Lin; Shih-Ching Chang
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.